Search

Your search keyword '"Krete, Marielle"' showing total 2 results
Start Over Author "Krete, Marielle" Topic carcinoma, ductal, breast
2 results on '"Krete, Marielle"'

1. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.

Author

Lips EH, Kumar T, Megalios A, Visser LL, Sheinman M, Fortunato A, Shah V, Hoogstraat M, Sei E, Mallo D, Roman-Escorza M, Ahmed AA, Xu M, van den Belt-Dusebout AW, Brugman W, Casasent AK, Clements K, Davies HR, Fu L, Grigoriadis A, Hardman TM, King LM, Krete M, Kristel P, de Maaker M, Maley CC, Marks JR, Menegaz BA, Mulder L, Nieboer F, Nowinski S, Pinder S, Quist J, Salinas-Souza C, Schaapveld M, Schmidt MK, Shaaban AM, Shami R, Sridharan M, Zhang J, Stobart H, Collyar D, Nik-Zainal S, Wessels LFA, Hwang ES, Navin NE, Futreal PA, Thompson AM, Wesseling J, and Sawyer EJ

Subjects
Biomarkers, Tumor analysis, Biomarkers, Tumor genetics, Female, Genomics, Humans, Neoplasm Recurrence, Local genetics, Breast Neoplasms genetics, Breast Neoplasms pathology, Carcinoma, Ductal, Breast genetics, Carcinoma, Intraductal, Noninfiltrating genetics, Carcinoma, Intraductal, Noninfiltrating pathology
Abstract

Ductal carcinoma in situ (DCIS) is the most common form of preinvasive breast cancer and, despite treatment, a small fraction (5-10%) of DCIS patients develop subsequent invasive disease. A fundamental biologic question is whether the invasive disease arises from tumor cells in the initial DCIS or represents new unrelated disease. To address this question, we performed genomic analyses on the initial DCIS lesion and paired invasive recurrent tumors in 95 patients together with single-cell DNA sequencing in a subset of cases. Our data show that in 75% of cases the invasive recurrence was clonally related to the initial DCIS, suggesting that tumor cells were not eliminated during the initial treatment. Surprisingly, however, 18% were clonally unrelated to the DCIS, representing new independent lineages and 7% of cases were ambiguous. This knowledge is essential for accurate risk evaluation of DCIS, treatment de-escalation strategies and the identification of predictive biomarkers., (© 2022. The Author(s).)

Published
2022
Full Text
View/download PDF

2. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer

Author

Lips, Esther H, Kumar, Tapsi, Megalios, Anargyros, Visser, Lindy L, Sheinman, Michael, Fortunato, Angelo, Shah, Vandna, Hoogstraat, Marlous, Sei, Emi, Mallo, Diego, Roman-Escorza, Maria, Ahmed, Ahmed A, Xu, Mingchu, Van Den Belt-Dusebout, Alexandra W, Brugman, Wim, Casasent, Anna K, Clements, Karen, Davies, Helen R, Fu, Liping, Grigoriadis, Anita, Hardman, Timothy M, King, Lorraine M, Krete, Marielle, Kristel, Petra, De Maaker, Michiel, Maley, Carlo C, Marks, Jeffrey R, Menegaz, Brian A, Mulder, Lennart, Nieboer, Frank, Nowinski, Salpie, Pinder, Sarah, Quist, Jelmar, Salinas-Souza, Carolina, Schaapveld, Michael, Schmidt, Marjanka K, Shaaban, Abeer M, Shami, Rana, Sridharan, Mathini, Zhang, John, Stobart, Hilary, Collyar, Deborah, Nik-Zainal, Serena, Wessels, Lodewyk FA, Hwang, E Shelley, Navin, Nicholas E, Futreal, P Andrew, Grand Challenge PRECISION Consortium, Thompson, Alastair M, Wesseling, Jelle, Sawyer, Elinor J, Lips, Esther H [0000-0003-3488-4935], Kumar, Tapsi [0000-0003-2825-3387], Megalios, Anargyros [0000-0002-7363-5184], Visser, Lindy L [0000-0001-7856-1981], Hoogstraat, Marlous [0000-0002-4916-1177], Mallo, Diego [0000-0002-9046-8859], Roman-Escorza, Maria [0000-0002-6259-5025], Ahmed, Ahmed A [0000-0002-0409-7589], Clements, Karen [0000-0003-0113-4409], Grigoriadis, Anita [0000-0003-3434-201X], Maley, Carlo C [0000-0002-0745-7076], Menegaz, Brian A [0000-0002-3020-5790], Pinder, Sarah [0000-0003-4167-8910], Shaaban, Abeer M [0000-0001-5784-8705], Collyar, Deborah [0000-0003-0886-0964], Nik-Zainal, Serena [0000-0001-5054-1727], Wessels, Lodewyk FA [0000-0002-1656-6995], Navin, Nicholas E [0000-0002-2106-8624], Futreal, P Andrew [0000-0001-8663-2671], Wesseling, Jelle [0000-0002-8940-2676], Sawyer, Elinor J [0000-0001-8285-4111], and Apollo - University of Cambridge Repository

Subjects
Carcinoma, Ductal, Breast, article, Breast Neoplasms, 631/67/1347, Genomics, 631/208/514/1948, body regions, Carcinoma, Intraductal, Noninfiltrating, Biomarkers, Tumor, Humans, Female, Neoplasm Recurrence, Local, skin and connective tissue diseases, neoplasms
Abstract

Funder: Career Development and Innovation Cancer Award, Guys & St Thomas’ Charity and the Cancer Research UK King’s Health Partners Centre at King’s College London., Funder: T32 Translational Genomics Fellowship (NIH), Funder: Single Cell Genomics CPRIT Core Facilities Grant (RP180684)., Ductal carcinoma in situ (DCIS) is the most common form of preinvasive breast cancer and, despite treatment, a small fraction (5-10%) of DCIS patients develop subsequent invasive disease. A fundamental biologic question is whether the invasive disease arises from tumor cells in the initial DCIS or represents new unrelated disease. To address this question, we performed genomic analyses on the initial DCIS lesion and paired invasive recurrent tumors in 95 patients together with single-cell DNA sequencing in a subset of cases. Our data show that in 75% of cases the invasive recurrence was clonally related to the initial DCIS, suggesting that tumor cells were not eliminated during the initial treatment. Surprisingly, however, 18% were clonally unrelated to the DCIS, representing new independent lineages and 7% of cases were ambiguous. This knowledge is essential for accurate risk evaluation of DCIS, treatment de-escalation strategies and the identification of predictive biomarkers.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results